| Name | Vabametkib |
|---|---|
| Synonyms | 1H-1,2,3-Triazolo[4,5-b]pyrazine, 1-[[(2S)-4-[5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-2-pyrimidinyl]-2-morpholinyl]methyl]-6-(1-methyl-1H-pyrazol-4-yl) |
| Description | Vabametkib is a potent inhibitor of hepatocyte growth factor receptor (HGFR). Vabametkib inhibits Hs746T cells proliferation and inhibits c-Met with an IC50 value of 7 nM. Vabametkib can be used as an antineoplastic agent[1][2]. |
|---|---|
| Related Catalog | |
| References |
[1]. WHO Drug Informat ion - World Health Organization (WHO). |
| Molecular Formula | C29H34N12O |
|---|---|
| Molecular Weight | 566.66 |